Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone

Six patients with myocarditis documented by biopsy, after a baseline right heart catheterization and echocardiogram, underwent treatment with azathioprine and prednisone. After 3 months of treatment, biopsy, right heart catheterization and echocardiogram were repeated. In addition to the immunosuppressive therapy, most patients received additional conventional medications for heart failure between evaluation periods (mean number of cardiac drugs increased from 1.7 +/- 1.0 to 2.7 +/- 0.05, p = 0.041). Mean heart rate decreased (105 +/- 14 to 84 +/- 13 beats/min, p = 0.016), as did pulmonary wedge pressure (23 +/- 8 to 12 +/- 4 mm Hg, p = 0.012). There were no significant changes in cardiac index (3.1 +/- 0.8 to 2.9 +/- 1.0 liters/min), end-diastolic dimension (62 +/- 13 to 62 +/- 12 mm) or fractional shortening (11 +/- 6 to 12 +/- 3%) with treatment. Complications from immunosuppressive therapy included severe soft tissue infection, acute psychosis and adrenal insufficiency in one patient each. The benefits from prednisone and azathioprine in this group of patients have not been demonstrated. Although heart rate and pulmonary wedge pressure decreased, these changes could be ascribed to increases in the conventional therapy for heart failure. Finally, there is a high incidence of side effects from prednisone and azathioprine therapy. These findings suggest that this unproven therapy for myocarditis should be limited to experimental protocols.

This article has been cited by other articles:

				K J Lee, B W McCrindle, D J Bohn, G J Wilson, G P Taylor, R M Freedom, J F Smallhorn, and L N Benson Clinical outcomes of acute myocarditis in childhood Heart, August 1, 1999; 82(2): 226 - 233. [Abstract] [Full Text] [PDF]

				J. Martin, K. Sarai, M. Schindler, A. v. d. Loo, M. Yoshitake, and F. Beyersdorf MEDOS HIA-VAD Biventricular Assist Device for Bridge to Recovery in Fulminant Myocarditis Ann. Thorac. Surg., April 1, 1997; 63(4): 1145 - 1146. [Abstract] [Full Text]

				M. Kodama, S. Zhang, H. Hanawa, M. Saeki, T. Inomata, K. Suzuki, S. Koyama, and A. Shibata Effects of 15-Deoxyspergualin on Experimental Autoimmune Giant Cell Myocarditis of the Rat Circulation, February 15, 1995; 91(4): 1116 - 1122. [Abstract] [Full Text]

				L. G. Lange and G. F. Schreiner Immune Mechanisms of Cardiac Disease N. Engl. J. Med., April 21, 1994; 330(16): 1129 - 1135. [Full Text]

				J.T. Lie Myocarditis and Endomyocardial Biopsy in Unexplained Heart Failure: A Diagnosis in Search of a Disease Ann Intern Med, October 1, 1988; 109(7): 525 - 528. [Abstract] [PDF]

				L. C. Chow, H. C. Dittrich, and R. Shabetai Endomyocardial Biopsy in Patients with Unexplained Congestive Heart Failure Ann Intern Med, October 1, 1988; 109(7): 535 - 539. [Abstract] [PDF]